Why Evidence Gaps Cluster Between Telehealth Visits
Telehealth does not remove clinical uncertainty; it redistributes it. During a virtual visit, a family physician may move from a medication review to a portal message about a lab trend, then to a pre-visit note for the next patient. Between those encounters, questions surface in short windows: What does the current guideline say about monitoring intervals? Which source supports this formulary alternative? Is this recommendation still current, and does it apply to the patient in front of me? Those are not abstract academic questions. They are clinical evidence search tasks that can shape the next message, prescription, referral, or handoff.
For hospitalists covering virtual cross-cover, primary care teams working through asynchronous inboxes, and pharmacists verifying medication-related questions, the challenge is rarely a lack of information. It is retrieving the right evidence quickly enough to be useful and precisely enough to be trusted. Clinicians often keep guideline PDFs open, rely on point-of-care resources, search PubMed, check society guidance, or review local formulary notes. Each step can be valuable, but each also adds context switching. Between virtual visits, context switching is expensive because the next patient is already waiting, and the inbox does not pause.
This is where AI clinical decision support is being explored as a retrieval aid rather than an answer machine. A clinician-facing tool can accept a natural-language question, return an evidence-based response with citations, and link to source materials such as peer-reviewed journals and clinical guidelines. In a telehealth workflow, that can reduce the distance between “I need to check this” and “I have a source I can verify.” The essential discipline remains unchanged: AI supports, and never replaces, clinical judgment. An AI-generated answer should be treated as a starting point for verification, not as a final authority.
Consider a common scenario: a primary care clinician reviewing a portal message between video visits needs to confirm whether a local guideline or national guidance should guide the next step. A pharmacist checking a refill request may want the original labeling or a guideline citation rather than a remembered rule of thumb. A hospitalist preparing for a virtual follow-up may need to compare sources before documenting a plan. In each case, the useful output is not only an answer but a traceable path back to the evidence. Privacy also matters. Clinicians should avoid entering unnecessary patient identifiers into any tool, follow organizational policy, and treat HIPAA considerations seriously, including minimum-necessary use and approved workflows.
A Practical Workflow: From Spoken Question to Verified Citation
The most reliable between-visit evidence workflow starts with a focused question. Instead of searching a broad topic, clinicians can frame the issue in the language they would use for a colleague: population, clinical context, intervention or decision point, and the outcome or recommendation they need to confirm. A spoken or typed natural-language query can be faster than constructing a complex search string, especially when the clinician is moving from one virtual room to the next. The goal is not to skip evidence appraisal; it is to shorten the retrieval step so more attention remains for verification and clinical reasoning.
Once an answer appears, the next step is source hierarchy. A guideline recommendation, a systematic review, a randomized trial, an observational study, and product labeling answer different kinds of questions. Clinicians should check whether the cited source matches the question being asked, whether it is current, and whether the patient context is similar enough to justify applying the evidence. If a response includes citations and clickable links, open them. Confirm the recommendation in the primary source rather than relying on the summary alone. If the AI-generated answer and the cited source diverge, the source should govern, and the clinician should escalate or seek a second opinion as appropriate.
Platforms such as ZoeMD are designed around clinician-facing natural-language questions and cited answers; clinicians evaluating a platform can see details about how citations and source links are presented before adopting it. That evaluation should include practical questions: Does the answer show enough context to verify the recommendation? Are the citations easy to open? Can the clinician distinguish a guideline from a journal article? Does the tool support desktop, tablet, and mobile use in ways that fit real telehealth work? The answers matter because evidence lookup between visits is a workflow problem as much as a knowledge problem.
A practical routine can help teams make this repeatable. First, ask the question in one or two sentences and note the decision it will inform. Second, review the cited source and its date. Third, compare the source with local policy, formulary, or specialty guidance when relevant. Fourth, document the source and the reasoning in the EHR according to local practice. Fifth, avoid copying patient identifiers into unapproved tools and follow organizational HIPAA considerations. For pharmacists and primary care teams, a brief “citation-first” habit can be built into inbox triage and pre-visit planning. The clinician remains responsible for the final judgment; the tool simply makes the evidence easier to find and check.
Designing EHR-Centred Evidence Retrieval That Holds Up in Telehealth
Evidence retrieval works best when it fits the environment where clinicians already work. In telehealth, that environment is often the EHR, a secure messaging portal, a video platform, and a browser arranged across one or two screens. An EHR-centred workflow does not necessarily mean every tool is embedded inside the EHR; it means the evidence lookup does not create unnecessary friction, duplicate documentation, or new privacy risks. Clinicians should understand what data a tool receives, where queries are stored, who can access them, and whether the organization has approved the tool for the intended use. They should not assume HIPAA compliance or institutional approval without confirmation.
Several service scenarios illustrate the difference between a convenient tool and a reliable workflow. In pre-visit planning, a family physician might check a guideline source before a scheduled video visit and save the citation for the note. During a visit, a clinician might use voice input to look up a point-of-care question while the patient waits, then verify the source before acting. Between visits, a pharmacist might review a medication-related message and compare the cited guidance with local formulary notes. A hospitalist preparing a virtual handoff might use a natural-language query to locate the relevant society guidance, then confirm the recommendation in the original document. In each case, the evidence lookup is brief, but the verification step is non-negotiable.
Teams can strengthen this workflow with governance that is proportionate to the risk. Primary care groups and pharmacy teams can set expectations for citation review, define when a second source is needed, and review examples in team meetings. They can also clarify which questions should never be entered into a tool because they contain unnecessary patient identifiers. Training should emphasize that AI clinical decision support is an aid to clinical evidence search, not a substitute for professional judgment, local policy, or specialist consultation. When a tool returns an answer with citations, the clinician should verify the cited source before acting. That expectation should be explicit, documented, and reinforced in onboarding.
The operational test is straightforward: does the evidence lookup fit the short gap between virtual visits, produce a citation the clinician can verify, and leave the clinician in control of the decision? If it adds another layer of uncertainty, it is not ready for the workflow. If it shortens the path to a trustworthy source while preserving privacy and professional accountability, it can be a useful support tool. The strongest telehealth evidence workflows will be those that keep the citation visible, the verification step routine, and the clinician’s judgment central.
Madrid-bred but perennially nomadic, Diego has reviewed avant-garde jazz in New Orleans, volunteered on organic farms in Laos, and broken down quantum-computing patents for lay readers. He keeps a 35 mm camera around his neck and a notebook full of dad jokes in his pocket.